These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 17764939)
1. The evolution of adjuvant endocrine therapy: developments since St Gallen 2005. Smith IE; Arnedos M Breast; 2007 Dec; 16 Suppl 2():S4-9. PubMed ID: 17764939 [TBL] [Abstract][Full Text] [Related]
2. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen. Carpenter R Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017 [TBL] [Abstract][Full Text] [Related]
3. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women. Mouridsen HT Curr Med Res Opin; 2006 Aug; 22(8):1609-21. PubMed ID: 16870085 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now? Baum M Eur J Cancer; 2005 Aug; 41(12):1667-77. PubMed ID: 16046117 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant endocrine therapy for early breast cancer. Andreetta C; Smith I Cancer Lett; 2007 Jun; 251(1):17-27. PubMed ID: 17150303 [TBL] [Abstract][Full Text] [Related]
6. Advances in adjuvant endocrine therapy for postmenopausal women. Lin NU; Winer EP J Clin Oncol; 2008 Feb; 26(5):798-805. PubMed ID: 18258989 [TBL] [Abstract][Full Text] [Related]
7. [Hormone therapy in breast cancer: the end of tamoxifen?]. Delozier T Bull Cancer; 2005 Feb; 92(2):142-50. PubMed ID: 15749643 [TBL] [Abstract][Full Text] [Related]
8. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis. Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595 [TBL] [Abstract][Full Text] [Related]
9. Current controversies in extended adjuvant endocrine therapy for early breast cancer. Snoj N; Paridaens R; Cufer T Curr Opin Oncol; 2008 Nov; 20(6):627-33. PubMed ID: 18841043 [TBL] [Abstract][Full Text] [Related]
10. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer. Toi M; Yamashiro H; Tsuji W Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765 [TBL] [Abstract][Full Text] [Related]
12. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer. Chlebowski RT Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792 [TBL] [Abstract][Full Text] [Related]
13. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082 [TBL] [Abstract][Full Text] [Related]
14. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors. Singh Ranger G J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044 [TBL] [Abstract][Full Text] [Related]
15. Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer. Bedard PL; Piccart-Gebhart MJ Curr Opin Oncol; 2009 Nov; 21(6):491-8. PubMed ID: 19593135 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant hormonal therapy in peri- and postmenopausal breast cancer. Ryan PD; Goss PE Oncologist; 2006; 11(7):718-31. PubMed ID: 16880231 [TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for oestrogen sensitive early breast cancer in post-menopausal women: meta-analyses of monotherapy, sequenced therapy and extended therapy. Josefsson ML; Leinster SJ Breast; 2010 Apr; 19(2):76-83. PubMed ID: 20096578 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer adjuvant endocrine therapy. Cigler T; Goss PE Cancer J; 2007; 13(3):148-55. PubMed ID: 17620763 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant endocrine treatment of early breast cancer. Lønning PE Hematol Oncol Clin North Am; 2007 Apr; 21(2):223-38. PubMed ID: 17512446 [TBL] [Abstract][Full Text] [Related]
20. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors. Hargis JB; Nakajima ST Cancer Invest; 2006 Mar; 24(2):174-7. PubMed ID: 16537187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]